Citations (170)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mani Iyer Prasanth, Dicson Sheeja Malar, Tewin Tencomnao & James Michael Brimson. (2021) The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s. Expert Opinion on Therapeutic Targets 25:5, pages 401-414.
Read now
Read now
Tangui Maurice. (2021) Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. Expert Opinion on Drug Discovery 16:4, pages 373-389.
Read now
Read now
Vladimir A Parfenov, Olga D Ostroumova, Tatiana M Ostroumova, Alexey I Kochetkov, Victoria V Fateeva, Kristina K Khacheva, Gulnara R Khakimova & Oleg I Epstein. (2019) Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments. Neuropsychiatric Disease and Treatment 15, pages 1381-1402.
Read now
Read now
Colin G. Rousseaux & Stephanie F. Greene. (2016) Sigma receptors [σRs]: biology in normal and diseased states. Journal of Receptors and Signal Transduction 36:4, pages 327-388.
Read now
Read now
Mellar P Davis. (2015) Sigma-1 receptors and animal studies centered on pain and analgesia. Expert Opinion on Drug Discovery 10:8, pages 885-900.
Read now
Read now
José Miguel Vela, Manuel Merlos & Carmen Almansa. (2015) Investigational sigma-1 receptor antagonists for the treatment of pain. Expert Opinion on Investigational Drugs 24:7, pages 883-896.
Read now
Read now
Shang-Yi A Tsai, Michael J Pokrass, Neal R Klauer, Nicole E De Credico & Tsung-Ping Su. (2014) Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders. Expert Opinion on Therapeutic Targets 18:12, pages 1461-1476.
Read now
Read now
Michał Skrzycki & Hanna Czeczot. (2013) Altered expression level of Sigma1 receptor gene in human colorectal cancer. Journal of Receptors and Signal Transduction 33:5, pages 313-318.
Read now
Read now
Articles from other publishers (162)
Chiara Orciani, Sonia Do Carmo, Morgan K. Foret, Helene Hall, Quentin Bonomo, Agustina Lavagna, Chunwei Huang & A. Claudio Cuello. (2023) Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology. Neurobiology of Aging 132, pages 220-232.
Crossref
Crossref
Wan‐Ru Yu & Hann‐Chorng Kuo. (2023) Multimodal therapies and strategies for the treatment of interstitial cystitis/bladder pain syndrome in Taiwan. LUTS: Lower Urinary Tract Symptoms.
Crossref
Crossref
Talha Siddiqui & Lokesh Kumar Bhatt. (2023) Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson’s Disease. Neurochemical Research 48:10, pages 2925-2935.
Crossref
Crossref
Pranshul Sethi, Sidharth Mehan, Zuber Khan & Swesha Chhabra. (2023) Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations. NeuroToxicology 98, pages 61-85.
Crossref
Crossref
Mimi Tang, Ting Liu, Yanmei Shen, Lu Wang, Ying Xue, Tingyu Zhao, Kaiqiang Xie, Zhicheng Gong & Tao Yin. (2023) Potential antidepressant-like effects of N-3 polyunsaturated fatty acids through inhibition of endoplasmic reticulum stress. Psychopharmacology 240:9, pages 1877-1889.
Crossref
Crossref
Katarzyna Szczepańska, Andrzej J. Bojarski, Piotr Popik & Natalia Malikowska-Racia. (2023) Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands. Pharmacological Reports.
Crossref
Crossref
Minh Ngoc Tran, Timea Medveczki, Balazs Besztercei, Gyorgy Torok, Attila J. Szabo, Xavier Gasull, Illes Kovacs, Andrea Fekete & Judit Hodrea. (2023) Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells. Life 13:7, pages 1581.
Crossref
Crossref
Judit Hodrea, Minh Ngoc Tran, Balazs Besztercei, Timea Medveczki, Attila J. Szabo, Laszlo Őrfi, Illes Kovacs & Andrea Fekete. (2023) Sigma-1 Receptor Agonist Fluvoxamine Ameliorates Fibrotic Response of Trabecular Meshwork Cells. International Journal of Molecular Sciences 24:14, pages 11646.
Crossref
Crossref
Taylor S. Robinson & Mahasin A. Osman. (2023) An Emerging Role for Sigma Receptor 1 in Personalized Treatment of Breast Cancer. Cancers 15:13, pages 3464.
Crossref
Crossref
Md Mominur Rahman, Md Rezaul Islam, Mst Afroza Alam Tumpa, Sheikh Shohag, Shakil khan shuvo, Jannatul Ferdous, Saima Akter Kajol, Abdullah S.M. Aljohani, Waleed Al Abdulmonem, Abdur Rauf & Muthu Thiruvengadam. (2023) Insights into the promising prospect of medicinal chemistry studies against neurodegenerative disorders. Chemico-Biological Interactions 373, pages 110375.
Crossref
Crossref
Francisco Javier Munguia-Galaviz, Alejandra Guillermina Miranda-Diaz, Miguel Alejandro Cardenas-Sosa & Raquel Echavarria. (2023) Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases. International Journal of Molecular Sciences 24:3, pages 1997.
Crossref
Crossref
Tobias Winge, Dirk Schepmann, Judith Schmidt, Constantin Daniliuc, Ernst-Ulrich Würthwein & Bernhard Wünsch. (2023)
Diastereoselective synthesis and structure–affinity relationships of
σ
1
receptor ligands with spirocyclic scaffold
. Organic & Biomolecular Chemistry.
Crossref
Crossref
Bénédicte Oxombre, Fahima Madouri, Anne-Sophie Journé, Séverine Ravez, Eloise Woitrain, Pascal Odou, Nathalie Duhal, Sandro Ninni, David Montaigne, Nadira Delhem, Patrick Vermersch & Patricia Melnyk. (2022) Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. International Journal of Molecular Sciences 23:19, pages 11893.
Crossref
Crossref
Hosein Nakhaee, Moein Zangiabadian, Reza Bayati, Mohammad Rahmanian, Amir Ghaffari Jolfayi & Sakineh Rakhshanderou. (2022) The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis. PLOS ONE 17:10, pages e0267423.
Crossref
Crossref
Yaoyao Qin, Weixing Xu, Kunpeng Li, Qi Luo, Xi Chen, Yue Wang, Lei Chen & Sha Sha. (2022) Repeated inhibition of sigma-1 receptor suppresses GABAA receptor expression and long-term depression in the nucleus accumbens leading to depressive-like behaviors. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Anna Gorący, Jakub Rosik, Bartosz Szostak, Łukasz Ustianowski, Klaudia Ustianowska & Jarosław Gorący. (2022) Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview. Viruses 14:5, pages 1092.
Crossref
Crossref
Catharina Holtschulte, Frederik Börgel, Stefanie Westphälinger, Dirk Schepmann, Gianluca Civenni, Erik Laurini, Domenico Marson, Carlo V. Catapano, Sabrina Pricl & Bernhard Wünsch. (2022)
Synthesis of Aminoethyl‐Substituted Piperidine Derivatives as σ
1
Receptor Ligands with Antiproliferative Properties
. ChemMedChem 17:7.
Crossref
Crossref
Yaeko Hashimoto, Takuji Suzuki & Kenji Hashimoto. (2022) Mechanisms of action of fluvoxamine for COVID-19: a historical review. Molecular Psychiatry 27:4, pages 1898-1907.
Crossref
Crossref
Jiali Chen, Guangying Li, Pingping Qin, Jiaojiao Chen, Na Ye, John L Waddington & Xuechu Zhen. (2022) Allosteric Modulation of the Sigma-1 Receptor Elicits Antipsychotic-like Effects. Schizophrenia Bulletin 48:2, pages 474-484.
Crossref
Crossref
Francesca S. Abatematteo, Philip D. Mosier, Mauro Niso, Leonardo Brunetti, Francesco Berardi, Fulvio Loiodice, Marialessandra Contino, Benjamin Delprat, Tangui Maurice, Antonio Laghezza & Carmen Abate. (2022) Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect. European Journal of Medicinal Chemistry 228, pages 114038.
Crossref
Crossref
Piotr F.J. Lipiński, Edina Szűcs, Małgorzata Jarończyk, Piotr Kosson, Sándor Benyhe, Aleksandra Misicka, Jan Cz Dobrowolski & Joanna Sadlej. 2022. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics
89
100
.
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckMellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care
1
40
.
Parthena Martin, Thadd Reeder, Jo Sourbron, Peter A. M. de Witte, Arnold R. Gammaitoni & Bradley S. Galer. (2021) An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies. International Journal of Molecular Sciences 22:16, pages 8416.
Crossref
Crossref
Harshavardhan Kenche, Meharvan Singh, Jacquez Smith & Kai Shen. (2021) Neuronal mitochondrial dysfunction in a cellular model of circadian rhythm disruption is rescued by donepezil. Biochemical and Biophysical Research Communications 567, pages 56-62.
Crossref
Crossref
Shailendra Pratap Singh, Salomon Amar, Pinky Gehlot, Sanjib K. Patra, Navjot Kanwar & Abhinav Kanwal. (2021) Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19. International Journal of Molecular Sciences 22:15, pages 8180.
Crossref
Crossref
Richa Aishwarya, Chowdhury S. Abdullah, Mahboob Morshed, Naznin Sultana Remex & Md. Shenuarin Bhuiyan. (2021) Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology. Frontiers in Physiology 12.
Crossref
Crossref
James Michael Brimson, Mani Iyer Prasanth, Ciro Isidoro, Monruedee Sukprasansap & Tewin Tencomnao. (2021) Cleistocalyx nervosum var. paniala seed extracts exhibit sigma-1 antagonist sensitive neuroprotective effects in PC12 cells and protects C. elegans from stress via the SKN-1/NRF-2 pathway. Nutrition and Healthy Aging 6:2, pages 131-146.
Crossref
Crossref
Nicole Kopp, Gianluca Civenni, Domenico Marson, Erik Laurini, Sabrina Pricl, Carlo V. Catapano, Hans-Ulrich Humpf, Carmen Almansa, Francisco Rafael Nieto, Dirk Schepmann & Bernhard Wünsch. (2021) Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ1 receptor affinity, antitumor and analgesic activity. European Journal of Medicinal Chemistry 219, pages 113443.
Crossref
Crossref
Héctor Torres-Gómez, Constantin Daniliuc, Dirk Schepmann, Erik Laurini, Sabrina Pricl & Bernhard Wünsch. (2021) Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity. International Journal of Molecular Sciences 22:11, pages 5685.
Crossref
Crossref
Jeffrey L. Barr, Pingwei Zhao, G. Cristina Brailoiu & Eugen Brailoiu. (2021) Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine. International Journal of Molecular Sciences 22:10, pages 5160.
Crossref
Crossref
Ashwini Ingole, Megha P Kadam, Aishwarya P. Dalu, Shital M Kute, Piyusha R Mange, Vaishali D Theng, Om R Lahane, Aniket P Nikas, Yash V Kawal, Shatrughna U. Nagrik & Prashant A. Patil. (2021) A Review of the Pharmacological Characteristics of Vanillic Acid. Journal of Drug Delivery and Therapeutics 11:2-S, pages 200-204.
Crossref
Crossref
Elisabeth Kronenberg, Frauke Weber, Dirk Schepmann & Bernhard Wünsch. (2021)
Synthesis and
σ
receptor affinity of spiro[[2]benzopyran-1,1′-cyclohexanes] with an exocyclic amino moiety in the 3′-position
. RSC Medicinal Chemistry 12:2, pages 237-244.
Crossref
Crossref
Hebaalla Agha & Christopher R. McCurdy. (2021)
In vitro
and
in vivo
sigma 1 receptor imaging studies in different disease states
. RSC Medicinal Chemistry 12:2, pages 154-177.
Crossref
Crossref
Kenji Hashimoto. (2021) Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor. European Archives of Psychiatry and Clinical Neuroscience 271:2, pages 249-258.
Crossref
Crossref
Theo Battista, Gianmarco Pascarella, David Sasah Staid, Gianni Colotti, Jessica Rosati, Annarita Fiorillo, Alessia Casamassa, Angelo Luigi Vescovi, Barbara Giabbai, Marta Stefania Semrau, Sergio Fanelli, Paola Storici, Ferdinando Squitieri, Veronica Morea & Andrea Ilari. (2021) Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. International Journal of Molecular Sciences 22:3, pages 1293.
Crossref
Crossref
Nicole Kopp, Catharina Holtschulte, Frederik Börgel, Kirstin Lehmkuhl, Kristina Friedland, Gianluca Civenni, Erik Laurini, Carlo V. Catapano, Sabrina Pricl, Hans-Ulrich Humpf, Dirk Schepmann & Bernhard Wünsch. (2021) Novel σ1 antagonists designed for tumor therapy: Structure – activity relationships of aminoethyl substituted cyclohexanes. European Journal of Medicinal Chemistry 210, pages 112950.
Crossref
Crossref
Jun Toyohara, Peter Brust, Hongmei Jia, Muneyuki Sakata & Kiichi Ishiwata. 2021. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
943
971
.
Na Ye, Wangzhi Qin, Sheng Tian, Qingfeng Xu, Eric A. Wold, Jia Zhou & Xue-Chu Zhen. (2020) Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of Medicinal Chemistry 63:24, pages 15187-15217.
Crossref
Crossref
Mikhail V. Voronin, Yulia V. Vakhitova & Sergei B. Seredenin. (2020) Chaperone Sigma1R and Antidepressant Effect. International Journal of Molecular Sciences 21:19, pages 7088.
Crossref
Crossref
Momoka Iwamoto, Yoki Nakamura, Masatoshi Takemura, Kazue Hisaoka-Nakashima & Norimitsu Morioka. (2020) TLR4-TAK1-p38 MAPK pathway and HDAC6 regulate the expression of sigma-1 receptors in rat primary cultured microglia. Journal of Pharmacological Sciences 144:1, pages 23-29.
Crossref
Crossref
Hongmei Jia, Zhengxin Cai, Daniel Holden, Yingfang He, Shu-fei Lin, Songye Li, Evan Baum, Anupama Shirali, Michael Kapinos, Hong Gao, Jim Ropchan & Yiyun Huang. (2020)
Positron Emission Tomography Imaging Evaluation of a Novel
18
F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys
. ACS Chemical Neuroscience 11:11, pages 1673-1681.
Crossref
Crossref
Robert P. Lisak, Liljana Nedelkoska & Joyce A. Benjamins. (2020) Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis. Journal of Neuroimmunology 342, pages 577188.
Crossref
Crossref
Antonis Ververis, Rana Dajani, Pantelitsa Koutsou, Ahmad Aloqaily, Carol Nelson-Williams, Erin Loring, Ala Arafat, Ammar Fayez Mubaidin, Khalid Horany, Mai B Bader, Yaqoub Al-Baho, Bushra Ali, Abdurrahman Muhtaseb, Tyrone DeSpenza Jr, Abdelkarim A Al-Qudah, Lefkos T Middleton, Eleni Zamba-Papanicolaou, Richard Lifton & Kyproula Christodoulou. (2020)
Distal hereditary motor neuronopathy of the Jerash type is caused by a novel
SIGMAR1
c.500A>T missense mutation
. Journal of Medical Genetics 57:3, pages 178-186.
Crossref
Crossref
Himanshu Bhatt, Sri Vishnu Kiran Rompicharla, Balaram Ghosh, Vladimir Torchilin & Swati Biswas. (2019) Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel. Nanomedicine 14:24, pages 3159-3176.
Crossref
Crossref
Olivier Soriani & Saïd Kourrich. (2019) The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer. Frontiers in Neuroscience 13.
Crossref
Crossref
Paul Bunse, Christoph Schlepphorst, Frank Glorius, Masato Kitamura & Bernhard Wünsch. (2019)
Short and Atom-Economic Enantioselective Synthesis of the σ
1
-Receptor Ligands (
S
)- and (
R
)-Fluspidine—Important Tools for Positron Emission Tomography Studies
. The Journal of Organic Chemistry 84:21, pages 13744-13754.
Crossref
Crossref
Kazuma Ogawa. (2019) Development of Diagnostic and Therapeutic Probes with Controlled Pharmacokinetics for Use in Radiotheranostics. Chemical and Pharmaceutical Bulletin 67:9, pages 897-903.
Crossref
Crossref
Simone Thum, Dirk Schepmann, Eva Ayet, Marta Pujol, Francisco R. Nieto, Simon M. Ametamey & Bernhard Wünsch. (2019) Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ1 receptor antagonists: Synthesis, receptor affinity, selectivity and antiallodynic activity. European Journal of Medicinal Chemistry 177, pages 47-62.
Crossref
Crossref
Marta Rui, Giacomo Rossino, Daniela Rossi & Simona Collina. 2019. Emerging Drugs and Targets for Multiple Sclerosis. Emerging Drugs and Targets for Multiple Sclerosis
264
284
.
Elli Zoupa, Achille Gravanis & Nikolaos Pitsikas. (2019) The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats. Neuropharmacology 151, pages 74-83.
Crossref
Crossref
Rosalia Pascual, Carmen Almansa, Carlos Plata-Salamán & José Miguel Vela. (2019) A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset. Frontiers in Pharmacology 10.
Crossref
Crossref
Mireia Carcolé, Daniel Zamanillo, Manuel Merlos, Begoña Fernández-Pastor, David Cabañero & Rafael Maldonado. (2019) Blockade of the Sigma-1 Receptor Relieves Cognitive and Emotional Impairments Associated to Chronic Osteoarthritis Pain. Frontiers in Pharmacology 10.
Crossref
Crossref
Kazuma Ogawa, Ryohei Masuda, Kenji Mishiro, Mengfei Wang, Takashi Kozaka, Kazuhiro Shiba, Seigo Kinuya & Akira Odani. (2019) Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging. Bioorganic & Medicinal Chemistry 27:10, pages 1990-1996.
Crossref
Crossref
Sílvia Castany, Xavier Codony, Daniel Zamanillo, Manuel Merlos, Enrique Verdú & Pere Boadas-Vaello. (2019) Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice. Frontiers in Pharmacology 10.
Crossref
Crossref
Yakup Albayrak, Murat Beyazyüz, Özlem Abbak & Ece Altındağ. (2019) A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine. Clinical Psychopharmacology and Neuroscience 17:1, pages 134-138.
Crossref
Crossref
Darren M. Riddy, Anna E. Cook, David M. Shackleford, Tracie L. Pierce, Elisabeth Mocaer, Clotilde Mannoury la Cour, Aurore Sors, William N. Charman, Roger J. Summers, Patrick M. Sexton, Arthur Christopoulos & Christopher J. Langmead. (2019) Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists. Neuropharmacology 144, pages 244-255.
Crossref
Crossref
Masaya Asano, Serika Motoike, Chika Yokota, Naoto Usuki, Hikaru Yamamoto, Tomoaki Urabe, Kazusa Katarao, Izumi Hide, Shigeru Tanaka, Masashi Kawamoto, Masahiro Irifune & Norio Sakai. (2019) SKF-10047, a prototype Sigma-1 receptor agonist, augmented the membrane trafficking and uptake activity of the serotonin transporter and its C-terminus-deleted mutant via a Sigma-1 receptor-independent mechanism. Journal of Pharmacological Sciences 139:1, pages 29-36.
Crossref
Crossref
Catherine F. Moore, Valentina Sabino, George F. Koob & Pietro Cottone. 2019. Compulsive Eating Behavior and Food Addiction. Compulsive Eating Behavior and Food Addiction
41
81
.
María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés-Montero, Javier Garzón & Pilar Sánchez-Blázquez. (2018) Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. Molecular Brain 11:1.
Crossref
Crossref
Chowdhury S. Abdullah, Shafiul Alam, Richa Aishwarya, Sumitra Miriyala, Manikandan Panchatcharam, Mohammad Alfrad Nobel Bhuiyan, Jonette M. Peretik, A. Wayne Orr, Jeanne James, Hanna Osinska, Jeffrey Robbins, John N. Lorenz & Md. Shenuarin Bhuiyan. (2018) Cardiac Dysfunction in the Sigma 1 Receptor Knockout Mouse Associated With Impaired Mitochondrial Dynamics and Bioenergetics. Journal of the American Heart Association 7:20.
Crossref
Crossref
Ryuta Morihara, Toru Yamashita, Xia Liu, Yumiko Nakano, Yusuke Fukui, Kota Sato, Yasuyuki Ohta, Nozomi Hishikawa, Jingwei Shang & Koji Abe. (2018) Protective effect of a novel sigma-1 receptor agonist is associated with reduced endoplasmic reticulum stress in stroke male mice. Journal of Neuroscience Research 96:10, pages 1707-1716.
Crossref
Crossref
Kazuma Ogawa, Ryohei Masuda, Yoshiaki Mizuno, Akira Makino, Takashi Kozaka, Yoji Kitamura, Yasushi Kiyono, Kazuhiro Shiba & Akira Odani. (2018) Development of a novel radiobromine-labeled sigma-1 receptor imaging probe. Nuclear Medicine and Biology 61, pages 28-35.
Crossref
Crossref
Héctor Torres-Gómez, Constantin Daniliuc, Dirk Schepmann & Bernhard Wünsch. (2018) Synthesis of 3-aza[4.4.3]propellanes with high σ1 receptor affinity. Bioorganic & Medicinal Chemistry 26:8, pages 1705-1712.
Crossref
Crossref
Omkara Swami Muddineti, Preeti Kumari, Balaram Ghosh & Swati Biswas. (2018) Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin. Pharmaceutical Research 35:5.
Crossref
Crossref
HuaLin Cai, Ting Cao, Xiang Zhou & Jeffrey K. Yao. (2018) Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications. Frontiers in Psychiatry 9.
Crossref
Crossref
Lena Fanter, Dirk Schepmann & Bernhard Wünsch. (2018)
Solid-phase organic synthesis of chiral, non-racemic 1,2,4-trisubstituted 1,4-diazepanes with high σ
1
receptor affinity
. Archiv der Pharmazie 351:1, pages 1700334.
Crossref
Crossref
Zhouli Cao, Qingling Xiao, Xiaoniu Dai, Zewei Zhou, Rong Jiang, Yusi Cheng, Xiyue Yang, Huifang Guo, Jing Wang, Zhaoqing Xi, Honghong Yao & Jie Chao. (2017) circHIPK2-mediated σ-1R promotes endoplasmic reticulum stress in human pulmonary fibroblasts exposed to silica. Cell Death & Disease 8:12.
Crossref
Crossref
Shivangi Patel, Dilip Sharma, Kiran Kalia & Vinod Tiwari. (2017) Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches. Neuroscience & Biobehavioral Reviews 83, pages 589-603.
Crossref
Crossref
Tieying Song, Jianhui Zhao, Xiaojing Ma, Zaiwang Zhang, Bo Jiang & Yunliang Yang. (2017) Role of sigma 1 receptor in high fat diet-induced peripheral neuropathy. Biological Chemistry 398:10, pages 1141-1149.
Crossref
Crossref
Lena Fanter, Christoph Müller, Dirk Schepmann, Franz Bracher & Bernhard Wünsch. (2017) Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands. Bioorganic & Medicinal Chemistry 25:17, pages 4778-4799.
Crossref
Crossref
Artur K. Kokornaczyk, Dirk Schepmann, Junichiro Yamaguchi, Kenichiro Itami, Erik Laurini, Maurizio Fermeglia, Sabrina Pricl & Bernhard Wünsch. (2017)
Thiazole-Based σ
1
Receptor Ligands: Diversity by Late-Stage C−H Arylation of Thiazoles, Structure-Affinity and Selectivity Relationships, and Molecular Interactions
. ChemMedChem 12:13, pages 1070-1080.
Crossref
Crossref
Inga Knappmann, Kirstin Lehmkuhl, Jens Köhler, Dirk Schepmann, Martin Giera, Franz Bracher & Bernhard Wünsch. (2017) Lipase-catalyzed kinetic resolution as key step in the synthesis of enantiomerically pure σ ligands with 2-benzopyran structure. Bioorganic & Medicinal Chemistry 25:13, pages 3384-3395.
Crossref
Crossref
Michael Remesic, Victor J. Hruby, Frank Porreca & Yeon Sun Lee. (2017) Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. ACS Chemical Neuroscience 8:6, pages 1147-1158.
Crossref
Crossref
Catherine F Moore, Valentina Sabino, George F Koob & Pietro Cottone. (2016) Pathological Overeating: Emerging Evidence for a Compulsivity Construct. Neuropsychopharmacology 42:7, pages 1375-1389.
Crossref
Crossref
Yingfang He, Fang Xie, Jiajun Ye, Winnie Deuther-Conrad, Bixiao Cui, Liang Wang, Jie Lu, Jörg Steinbach, Peter Brust, Yiyun Huang, Jie Lu & Hongmei Jia. (2017)
1-(4-[
18
F]Fluorobenzyl)-4-[(tetrahydrofuran-2-yl)methyl]piperazine: A Novel Suitable Radioligand with Low Lipophilicity for Imaging σ
1
Receptors in the Brain
. Journal of Medicinal Chemistry 60:10, pages 4161-4172.
Crossref
Crossref
Laura Mandelli, Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Chi-Un Pae & Alessandro Serretti. (2017) The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder. Advances in Therapy 34:3, pages 713-724.
Crossref
Crossref
Tetsuya Ezawa, Yuya Kawashima, Takuya Noguchi, Seunghee Jung & Nobuyuki Imai. (2017) Convenient synthesis of memantine analogues containing a chiral cyclopropane skeleton as a sigma-1 receptor agonist. Tetrahedron: Asymmetry 28:2, pages 266-281.
Crossref
Crossref
Susan Z. Lever, Kuo-Hsien Fan & John R. Lever. (2017) Tactics for preclinical validation of receptor-binding radiotracers. Nuclear Medicine and Biology 44, pages 4-30.
Crossref
Crossref
Frauke Weber, Peter Brust, Erik Laurini, Sabrina Pricl & Bernhard Wünsch. 2017. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Sigma Receptors: Their Role in Disease and as Therapeutic Targets
31
48
.
Yakup Albayrak & Kenji Hashimoto. 2017. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Sigma Receptors: Their Role in Disease and as Therapeutic Targets
153
161
.
Saïd Kourrich. 2017. Sigma Proteins: Evolution of the Concept of Sigma Receptors. Sigma Proteins: Evolution of the Concept of Sigma Receptors
109
130
.
J. M. Entrena, C. Sánchez-Fernández, F. R. Nieto, R. González-Cano, S. Yeste, E. J. Cobos & J. M. Baeyens. (2016) Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin. Scientific Reports 6:1.
Crossref
Crossref
Christian Wiese, Eva Große Maestrup, Fabian Galla, Dirk Schepmann, Achim Hiller, Steffen Fischer, Friedrich-Alexander Ludwig, Winnie Deuther-Conrad, Cornelius K. Donat, Peter Brust, Lars Büter, Uwe Karst & Bernhard Wünsch. (2016)
Comparison of in Silico, Electrochemical, in Vitro and in Vivo Metabolism of a Homologous Series of (Radio)fluorinated σ
1
Receptor Ligands Designed for Positron Emission Tomography
. ChemMedChem 11:21, pages 2445-2458.
Crossref
Crossref
Janine Stefaowitz, Dirk Schepmann, Constantin Daniliuc, Susumu Saito & Bernhard Wünsch. (2016) Synthesis of morphan derivatives with additional substituents in 8-position. Zeitschrift für Naturforschung B 71:10, pages 1057-1069.
Crossref
Crossref
Inga Knappmann, Dirk Schepmann & Bernhard Wünsch. (2016) Oxa-Pictet–Spengler reaction as key step in the synthesis of novel σ receptor ligands with 2-benzopyran structure. Bioorganic & Medicinal Chemistry 24:18, pages 4045-4055.
Crossref
Crossref
María Rodríguez-Muñoz, Pilar Sánchez-Blázquez, Manuel Merlos & Javier Garzón-Niño. (2016) Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. Oncotarget 7:34, pages 55840-55862.
Crossref
Crossref
Jiajun Ye, Xia Wang, Winnie Deuther-Conrad, Jinming Zhang, Jianzhou Li, Xiaojun Zhang, Liang Wang, Jörg Steinbach, Peter Brust & Hongmei Jia. (2016)
Synthesis and evaluation of a
18
F-labeled 4-phenylpiperidine-4-carbonitrile radioligand for σ
1
receptor imaging
. Journal of Labelled Compounds and Radiopharmaceuticals 59:9, pages 332-339.
Crossref
Crossref
Yun Wang, Lin Guo, Hua‐Feng Jiang, Long‐Tai Zheng, Ao Zhang & Xue‐Chu Zhen. (2016) Allosteric Modulation of Sigma‐1 Receptors Elicits Rapid Antidepressant Activity. CNS Neuroscience & Therapeutics 22:5, pages 368-377.
Crossref
Crossref
Jonathan L. Katz, Weimin C. Hong, Takato Hiranita & Tsung-Ping Su. (2016) A role for sigma receptors in stimulant self-administration and addiction. Behavioural Pharmacology 27:2 and 3 - Special Issue, pages 100-115.
Crossref
Crossref
Tsung-Ping Su, Tzu-Chieh Su, Yoki Nakamura & Shang-Yi Tsai. (2016) The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems. Trends in Pharmacological Sciences 37:4, pages 262-278.
Crossref
Crossref
Lilla Lenart, Judit Hodrea, Adam Hosszu, Sandor Koszegi, Dora Zelena, Dora Balogh, Edgar Szkibinszkij, Apor Veres-Szekely, Laszlo Wagner, Adam Vannay, Attila J. Szabo & Andrea Fekete. (2016) The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats. Psychopharmacology 233:7, pages 1269-1278.
Crossref
Crossref
Yuko Yasui & Tsung-Ping Su. (2016) Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine. Journal of Drug and Alcohol Research 5, pages 1-15.
Crossref
Crossref
Abraham Fisher, Ilya Bezprozvanny, Lili Wu, Daniel A. Ryskamp, Nira Bar-Ner, Niva Natan, Rachel Brandeis, Hanoch Elkon, Victoria Nahum, Eitan Gershonov, Frank M. LaFerla & Rodrigo Medeiros. (2016) AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer's Disease. Neurodegenerative Diseases 16:1-2, pages 95-110.
Crossref
Crossref
L.F. Tófoli & D.B. de Araujo. 2016. Imaging the Addicted Brain. Imaging the Addicted Brain
157
185
.
Luz Romero, Manuel Merlos & José Miguel Vela. 2016. Pharmacological Mechanisms and the Modulation of Pain. Pharmacological Mechanisms and the Modulation of Pain
179
215
.
Derek K. Tracy, Caroline Caddy & Sukhwinder S. Shergill. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
687
706
.
Tomohisa Mori & Tsutomu Suzuki. 2018. The Behavioral Neuroscience of Drug Discrimination. The Behavioral Neuroscience of Drug Discrimination
141
152
.
Hitoshi Tanimukai & Takashi Kudo. (2015) Fluvoxamine alleviates paclitaxel-induced neurotoxicity. Biochemistry and Biophysics Reports 4, pages 202-206.
Crossref
Crossref
María Rodríguez-Muñoz, Elsa Cortés-Montero, Andrea Pozo-Rodrigálvarez, Pilar Sánchez-Blázquez & Javier Garzón-Niño. (2015) The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders. Oncotarget 6:34, pages 35458-35477.
Crossref
Crossref
Ferdinando Squitieri, Alba Di Pardo, Mariagrazia Favellato, Enrico Amico, Vittorio Maglione & Luigi Frati. (2015) Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model. Journal of Cellular and Molecular Medicine 19:11, pages 2540-2548.
Crossref
Crossref
Kazuma Ogawa, Yoshiaki Mizuno, Kohshin Washiyama, Kazuhiro Shiba, Naruto Takahashi, Takashi Kozaka, Shigeki Watanabe, Atsushi Shinohara & Akira Odani. (2015) Preparation and evaluation of an astatine-211-labeled sigma receptor ligand for alpha radionuclide therapy. Nuclear Medicine and Biology 42:11, pages 875-879.
Crossref
Crossref
Mori Tomohisa, Ohya Junpei, Masumoto Aki, Harumiya Masato, Fukase Mika, Yoshizawa Kazumi, Hayashi Teruo & Suzuki Tsutomu. (2015) Possible involvement of the sigma-1 receptor chaperone in chemotherapeutic-induced neuropathic pain. Synapse 69:11, pages 526-532.
Crossref
Crossref
Zhuang Wu, Linlang Li, Long-Tai Zheng, Zhihong Xu, Lin Guo & Xuechu Zhen. (2015) Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation. Journal of Neurochemistry 134:5, pages 904-914.
Crossref
Crossref
Kristoffer Sahlholm, Jurgen W. A. Sijbesma, Bram Maas, Chantal Kwizera, Daniel Marcellino, Nisha K. Ramakrishnan, Rudi A. J. O. Dierckx, Philip H. Elsinga & Aren van Waarde. (2015) Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses. Psychopharmacology 232:18, pages 3443-3453.
Crossref
Crossref
Fang Xie, Ralf Bergmann, Torsten Kniess, Winnie Deuther-Conrad, Constantin Mamat, Christin Neuber, Boli Liu, Jörg Steinbach, Peter Brust, Jens Pietzsch & Hongmei Jia. (2015)
18
F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ
1
Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent
. Journal of Medicinal Chemistry 58:14, pages 5395-5407.
Crossref
Crossref
Maninder Malik, Claudia Rangel-Barajas, Nathalie Sumien, Chang Su, Meharvan Singh, Zhenglan Chen, Ren-Qi Huang, Johann Meunier, Tangui Maurice, Robert H Mach & Robert R Luedtke. (2015) The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice. British Journal of Pharmacology 172:10, pages 2519-2531.
Crossref
Crossref
David Baumeister, Luis M. Tojo & Derek K. Tracy. (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology 5:2, pages 97-132.
Crossref
Crossref
Teruo Hayashi. (2015) Conversion of psychological stress into cellular stress response: Roles of the sigma‐1 receptor in the process. Psychiatry and Clinical Neurosciences 69:4, pages 179-191.
Crossref
Crossref
James E. Barrett. (2015) The pain of pain: Challenges of animal behavior models. European Journal of Pharmacology 753, pages 183-190.
Crossref
Crossref
Olivia F. O’Leary, Timothy G. Dinan & John F. Cryan. (2015) Faster, better, stronger: Towards new antidepressant therapeutic strategies. European Journal of Pharmacology 753, pages 32-50.
Crossref
Crossref
Blanca Estela Jaramillo-Loranca, Linda Garcés-Ramírez, Alicia Angélica Munguía Rosales, Carolina Luna Ramírez, Genaro Vargas Hernández, Oscar Morales-Dionisio, Kateri González-Elizalde, Gonzalo Flores, Sergio Zamudio & Fidel De La Cruz-López. (2015)
The sigma agonist 1,3-Di-
o
-tolyl-guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats
. Synapse 69:4, pages 213-225.
Crossref
Crossref
Kenji Hashimoto. (2015) Targeting the sigma-1 receptor chaperone in the treatment of perinatal brain injury. Experimental Neurology 265, pages 118-121.
Crossref
Crossref
Marion Donnier-Maréchal, Pascal Carato, Delphine Le Broc, Christophe Furman & Patricia Melnyk. (2015) Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands. European Journal of Medicinal Chemistry 92, pages 575-582.
Crossref
Crossref
Jose Luis Ortega-Roldan, Felipe Ossa, Nader T. Amin & Jason R. Schnell. (2015) Solution NMR studies reveal the location of the second transmembrane domain of the human sigma‐1 receptor. FEBS Letters 589:5, pages 659-665.
Crossref
Crossref
Yasuo Miki, Kunikazu Tanji, Fumiaki Mori & Koichi Wakabayashi. (2015) Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease. Neurobiology of Disease 74, pages 25-31.
Crossref
Crossref
Daniela Rossi, Annamaria Marra, Marta Rui, Erik Laurini, Maurizio Fermeglia, Sabrina Pricl, Dirk Schepmann, Bernhard Wuensch, Marco Peviani, Daniela Curti & Simona Collina. (2015) A step forward in the sigma enigma: a role for chirality in the sigma1 receptor–ligand interaction?. MedChemComm 6:1, pages 138-146.
Crossref
Crossref
Kenji Hashimoto. (2015) Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. Journal of Pharmacological Sciences 127:1, pages 6-9.
Crossref
Crossref
Teruo Hayashi. (2015) Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs. Journal of Pharmacological Sciences 127:1, pages 2-5.
Crossref
Crossref
Rong Xu, Sarah A. Lord, Ryan M. Peterson, Emily A. Fergason-Cantrell, John R. Lever & Susan Z. Lever. (2015) Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): Effects on binding affinity and selectivity for sigma receptors and monoamine transporters. Bioorganic & Medicinal Chemistry 23:1, pages 222-230.
Crossref
Crossref
Pilar Sánchez-Blázquez, María Rodríguez-Muñoz, Raquel Herrero-Labrador, Javier Burgueño, Daniel Zamanillo & Javier Garzón. (2014) The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. The International Journal of Neuropsychopharmacology 17:12, pages 1943-1955.
Crossref
Crossref
Roman UrferHans J. MoebiusDavid SkoloudikEstevo SantamarinaWakao SatoShiro MitaKeith W. Muir. (2014) Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke. Stroke 45:11, pages 3304-3310.
Crossref
Crossref
Anthony C. Johnson & Beverley Greenwood-Van Meerveld. (2014) Stress-Induced Pain: A Target for the Development of Novel Therapeutics. Journal of Pharmacology and Experimental Therapeutics 351:2, pages 327-335.
Crossref
Crossref
Yuan-Yuan Chen, Xia Wang, Jin-Ming Zhang, Winnie Deuther-Conrad, Xiao-Jun Zhang, Yiyun Huang, Yan Li, Jia-Jun Ye, Meng-Chao Cui, Jörg Steinbach, Peter Brust, Bo-Li Liu & Hong-Mei Jia. (2014) Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent. Bioorganic & Medicinal Chemistry 22:19, pages 5270-5278.
Crossref
Crossref
Xia Wang, Dan Li, Winnie Deuther-Conrad, Jie Lu, Ying Xie, Bing Jia, Mengchao Cui, Jörg Steinbach, Peter Brust, Boli Liu & Hongmei Jia. (2014)
Novel Cyclopentadienyl Tricarbonyl
99m
Tc Complexes Containing 1-Piperonylpiperazine Moiety: Potential Imaging Probes for Sigma-1 Receptors
. Journal of Medicinal Chemistry 57:16, pages 7113-7125.
Crossref
Crossref
T Omi, H Tanimukai, D Kanayama, Y Sakagami, S Tagami, M Okochi, T Morihara, M Sato, K Yanagida, A Kitasyoji, H Hara, K Imaizumi, T Maurice, N Chevallier, S Marchal, M Takeda & T Kudo. (2014) Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor. Cell Death & Disease 5:7, pages e1332-e1332.
Crossref
Crossref
E.I. Solntseva, N.A. Kapai, O.V. Popova, P.D. Rogozin & V.G. Skrebitsky. (2014) The involvement of sigma1 receptors in donepezil-induced rescue of hippocampal LTP impaired by beta-amyloid peptide. Brain Research Bulletin 106, pages 56-61.
Crossref
Crossref
Carmen Almansa & José Miguel Vela. (2014) Selective sigma-1 receptor antagonists for the treatment of pain. Future Medicinal Chemistry 6:10, pages 1179-1199.
Crossref
Crossref
Suping Bai, Shihong Li, Jinbin Xu, Xin Peng, Kiran Sai, Wenhua Chu, Zhude Tu, Chenbo Zeng & Robert H. Mach. (2014)
Synthesis and Structure–Activity Relationship Studies of Conformationally Flexible Tetrahydroisoquinolinyl Triazole Carboxamide and Triazole Substituted Benzamide Analogues as σ
2
Receptor Ligands
. Journal of Medicinal Chemistry 57:10, pages 4239-4251.
Crossref
Crossref
Alba Vidal-Torres, Begoña Fernández-Pastor, Alicia Carceller, José Miguel Vela, Manuel Merlos & Daniel Zamanillo. (2014) Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats. Journal of Neurochemistry 129:3, pages 484-494.
Crossref
Crossref
Yasuo Miki, Fumiaki Mori, Tomoya Kon, Kunikazu Tanji, Yasuko Toyoshima, Mari Yoshida, Hidenao Sasaki, Akiyoshi Kakita, Hitoshi Takahashi & Koichi Wakabayashi. (2014) Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases. Neuropathology 34:2, pages 148-158.
Crossref
Crossref
Kazuki Terada, Nobuo Izumo, Biora Suzuki, Yoshiharu Karube, Tomomi Morikawa, Yukiko Ishibashi, Toshiki Kameyama, Koji Chiba, Noriko Sasaki, Keiko Iwata, Hideo Matsuzaki & Takayuki Manabe. (2014) Fluvoxamine moderates reduced voluntary activity following chronic dexamethasone infusion in mice via recovery of BDNF signal cascades. Neurochemistry International 69, pages 9-13.
Crossref
Crossref
Tamaki Ishima, Yuko Fujita & Kenji Hashimoto. (2014) Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. European Journal of Pharmacology 727, pages 167-173.
Crossref
Crossref
L Zvejniece, E Vavers, B Svalbe, R Vilskersts, I Domracheva, M Vorona, G Veinberg, I Misane, I Stonans, I Kalvinsh & M Dambrova. (2014)
The cognition‐enhancing activity of
E1R
, a novel positive allosteric modulator of sigma‐1 receptors
. British Journal of Pharmacology 171:3, pages 761-771.
Crossref
Crossref
Aurélie Maisonial-Besset, Uta Funke, Barbara Wenzel, Steffen Fischer, Katharina Holl, Bernhard Wünsch, Jörg Steinbach & Peter Brust. (2014) Automation of the radiosynthesis and purification procedures for [18F]Fluspidine preparation, a new radiotracer for clinical investigations in PET imaging of σ1 receptors in brain. Applied Radiation and Isotopes 84, pages 1-7.
Crossref
Crossref
Rae R. Matsumoto, Linda Nguyen, Nidhi Kaushal & Matthew J. Robson. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
323
386
.
Jun Toyohara, Muneyuki Sakata & Kiichi Ishiwata. 2014. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
741
763
.
Daniel Zamanillo, Luz Romero, Manuel Merlos & José Miguel Vela. (2013) Sigma 1 receptor: A new therapeutic target for pain. European Journal of Pharmacology 716:1-3, pages 78-93.
Crossref
Crossref
Alba Vidal-Torres, Beatriz de la Puente, Maria Rocasalbas, Clara Touriño, Simona Andreea Bura, Begoña Fernández-Pastor, Luz Romero, Xavier Codony, Daniel Zamanillo, Helmut Buschmann, Manuel Merlos, José Manuel Baeyens, Rafael Maldonado & José Miguel Vela. (2013) Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects. European Journal of Pharmacology 711:1-3, pages 63-72.
Crossref
Crossref
Yan Li, Xia Wang, Jinming Zhang, Winnie Deuther-Conrad, Fang Xie, Xiaojun Zhang, Jian Liu, Jinping Qiao, Mengchao Cui, Jörg Steinbach, Peter Brust, Boli Liu & Hongmei Jia. (2013)
Synthesis and Evaluation of Novel
18
F-Labeled Spirocyclic Piperidine Derivatives as σ
1
Receptor Ligands for Positron Emission Tomography Imaging
. Journal of Medicinal Chemistry 56:9, pages 3478-3491.
Crossref
Crossref
Grigory Veinberg, Maxim Vorona, Liga Zvejniece, Reinis Vilskersts, Edijs Vavers, Edvards Liepinsh, Helena Kazoka, Sergey Belyakov, Anatoly Mishnev, Jevgenijs Kuznecovs, Sergejs Vikainis, Natalja Orlova, Anton Lebedev, Yuri Ponomaryov & Maija Dambrova. (2013) Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor. Bioorganic & Medicinal Chemistry 21:10, pages 2764-2771.
Crossref
Crossref
Daniela Rossi, Annamaria Marra, Pietro Picconi, Massimo Serra, Laura Catenacci, Milena Sorrenti, Erik Laurini, Maurizio Fermeglia, Sabrina Pricl, Stefania Brambilla, Nicoletta Almirante, Marco Peviani, Daniela Curti & Simona Collina. (2013) Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-Scale synthesis, physicochemical characterization and in vitro metabolic stability. Bioorganic & Medicinal Chemistry 21:9, pages 2577-2586.
Crossref
Crossref
H. Kažoka, O. Koliškina, G. Veinberg & M. Vorona. (2013) Separation of piracetam derivatives on polysaccharide-based chiral stationary phases. Journal of Chromatography A 1281, pages 160-165.
Crossref
Crossref
Yakup AlbayrakKenji Hashimoto. (2013) Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases. Psychiatry Investigation 10:4, pages 417.
Crossref
Crossref
Madhavi L Bangaru, Dorothee Weihrauch, Qing-Bo Tang, Vasiliki Zoga, Quinn Hogan & Hsiang-en Wu. (2013) Sigma-1 Receptor Expression in Sensory Neurons and the Effect of Painful Peripheral Nerve Injury. Molecular Pain 9, pages 1744-8069-9-47.
Crossref
Crossref
K Sahlholm, P Århem, K Fuxe & D Marcellino. (2012) The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor. Molecular Psychiatry 18:1, pages 12-14.
Crossref
Crossref
Kenji Hashimoto. (2013) Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression. Progress in Neurobiology 100, pages 15-29.
Crossref
Crossref
Xia Wang, Yan Li, Winnie Deuther-Conrad, Fang Xie, Xin Chen, Meng-Chao Cui, Xiao-Jun Zhang, Jin-Ming Zhang, Jörg Steinbach, Peter Brust, Bo-Li Liu & Hong-Mei Jia. (2013) Synthesis and biological evaluation of 18F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging. Bioorganic & Medicinal Chemistry 21:1, pages 215-222.
Crossref
Crossref
Teruo Hayashi, Eri Hayashi, Michiko Fujimoto, Hein Sprong & Tsung-Ping Su. (2012) The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones. Journal of Biological Chemistry 287:51, pages 43156-43169.
Crossref
Crossref
Saïd Kourrich, Tsung-Ping Su, Michiko Fujimoto & Antonello Bonci. (2012) The sigma-1 receptor: roles in neuronal plasticity and disease. Trends in Neurosciences 35:12, pages 762-771.
Crossref
Crossref
Pietro Cottone, Xiaofan Wang, Jin Won Park, Marta Valenza, Angelo Blasio, Jina Kwak, Malliga R Iyer, Luca Steardo, Kenner C Rice, Teruo Hayashi & Valentina Sabino. (2012) Antagonism of Sigma-1 Receptors Blocks Compulsive-Like Eating. Neuropsychopharmacology 37:12, pages 2593-2604.
Crossref
Crossref
Yuichiro Watanabe, Ayako Nunokawa, Naoshi Kaneko, Masako Shibuya, Jun Egawa & Toshiyuki Someya. (2012) Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: A case–control study and an updated meta-analysis. Schizophrenia Research 141:2-3, pages 279-280.
Crossref
Crossref
Xin Chen, Meng-Chao Cui, Winnie Deuther-Conrad, Ying-Feng Tu, Teng Ma, Ying Xie, Bing Jia, Yan Li, Fang Xie, Xia Wang, Jörg Steinbach, Peter Brust, Bo-Li Liu & Hong-Mei Jia. (2012) Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging. Bioorganic & Medicinal Chemistry Letters 22:20, pages 6352-6357.
Crossref
Crossref
Kenji Hashimoto & Tsutomu Furuse. (2011) Sigma‐1 receptor agonist fluvoxamine for delirium in older adults. International Journal of Geriatric Psychiatry 27:9, pages 981-983.
Crossref
Crossref
Michiko Fujimoto, Teruo Hayashi, Roman Urfer, Shiro Mita & Tsung-Ping Su. (2012) Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor. Synapse 66:7, pages 630-639.
Crossref
Crossref
Giuseppe Gasparre, Carmen Abate, Francesco Berardi & Giuseppe Cassano. (2012) The sigma-1 receptor antagonist PB212 reduces the Ca2+-release through the inositol (1, 4, 5)-trisphosphate receptor in SK-N-SH cells. European Journal of Pharmacology 684:1-3, pages 59-63.
Crossref
Crossref
Tamaki Ishima & Kenji Hashimoto. (2012) Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 Receptors. PLoS ONE 7:5, pages e37989.
Crossref
Crossref
Daniel Zamanillo, Enrique Portillo‐Salido, José Miguel Vela & Luz Romero. 2012. Therapeutic Targets. Therapeutic Targets
225
278
.
Susan Z. Lever, Rong Xu, Kuo-Hsien Fan, Emily A. Fergason-Cantrell, Terry L. Carmack, Lisa D. Watkinson & John R. Lever. (2012) Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs. Nuclear Medicine and Biology 39:3, pages 401-414.
Crossref
Crossref
Robert R. Luedtke, Evelyn Perez, Shao-Hua Yang, Ran Liu, Suwanna Vangveravong, Zhude Tu, Robert H. Mach & James W. Simpkins. (2012) Neuroprotective effects of high affinity sigma 1 receptor selective compounds. Brain Research 1441, pages 17-26.
Crossref
Crossref
Akira Kishimoto, Motonori Kaneko, Yurie Gotoh & Kenji Hashimoto. (2012) Ifenprodil for the Treatment of Flashbacks in Female Posttraumatic Stress Disorder Patients with a History of Childhood Sexual Abuse. Biological Psychiatry 71:4, pages e7-e8.
Crossref
Crossref
Jonathan L. Katz, Tsung-Ping Su, Takato Hiranita, Teruo Hayashi, Gianluigi Tanda, Theresa Kopajtic & Shang-Yi Tsai. (2011) A Role for Sigma Receptors in Stimulant Self Administration and Addiction. Pharmaceuticals 4:6, pages 880-914.
Crossref
Crossref
Michiko Fujimoto & Teruo Hayashi. 2011.
73
117
.